sorafenib has been researched along with Leishmaniasis, Cutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alemomen, M; Saberi, S; Taymouri, S; Varshosaz, J | 1 |
1 other study(ies) available for sorafenib and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Preparation, optimization, and in vitro-in vivo evaluation of sorafenib-loaded polycaprolactone and cellulose acetate nanofibers for the treatment of cutaneous leishmaniasis.
Topics: Animals; Leishmaniasis, Cutaneous; Mice; Nanofibers; Polymers; Sorafenib | 2023 |